We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Green Laser Delivers Enhanced Therapy for Enlarged Prostates

By HospiMedica International staff writers
Posted on 08 Apr 2010
An upgraded green light laser provides more kilojoules (MoJo) to extend fiber life, remove more tissue, and treat larger prostate glands.

The GreenLight MoJo HPS laser-therapy treatment system now incorporates a software upgrade that delivers up to 400 kJ, for more efficient treatment of an enlarged prostate or benign prostatic hyperplasia (BPH) tumors of a size greater than 80 g, all with a single fiber. More...
In addition to improved capacity, the upgrade includes a new "time out" feature that allows for total operative time of up to 150 minutes; thus, while the average GreenLight procedure takes just 50 minutes, the added feature extends the total operative time for physicians who are new to the system, or are not yet as efficient in their technique. The increased procedural speed also helps reduce treatment costs by eliminating fiber changes during each case. The GreenLight MoJo HPS laser is a product of American Medical Systems (AMS; Minnetonka, MN, USA). The MoJo upgrade will also be provided free of charge during the next preventative maintenance visit for owners of current GreenLight HPS consoles still under the base warranty.

"The new MoJo upgrade allows GreenLight physicians to treat a wider range of cases with greater confidence and may provide better surgical outcomes by allowing for the removal of more tissue with a single fiber,” said Joe Martin, senior vice president and general manager of BPH Therapies at AMS. "A simple software upgrade is all it takes to significantly improve the power and performance of this proven treatment.”

"GreenLight users may now be able to reduce as much prostatic volume with MoJo as with more invasive TURP [transurethral resection of the prostate] procedures, providing yet another treatment option for patients whose BPH causes troubling symptoms,” added Mr. Martin. "This is particularly important for patients with a medical history that reduces their candidacy for other forms of treatment.”

Related Links:

American Medical Systems



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.